X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (186) 186
oncology (173) 173
ixabepilone (161) 161
index medicus (159) 159
female (139) 139
breast cancer (101) 101
chemotherapy (100) 100
breast neoplasms - drug therapy (96) 96
epothilones - therapeutic use (86) 86
cancer (83) 83
epothilone-b analog (82) 82
paclitaxel (81) 81
anthracycline (78) 78
antineoplastic agents - therapeutic use (77) 77
bms-247550 (77) 77
ixabepilone bms-247550 (76) 76
middle aged (71) 71
epothilones - adverse effects (64) 64
taxane (62) 62
epothilones - administration & dosage (60) 60
aged (59) 59
phase-ii (58) 58
epothilones (57) 57
pharmacology & pharmacy (57) 57
adult (56) 56
male (55) 55
ii clinical-trial (54) 54
treatment outcome (52) 52
metastatic breast cancer (51) 51
breast neoplasms - pathology (49) 49
capecitabine (48) 48
care and treatment (48) 48
tubulin modulators - therapeutic use (48) 48
drug resistance, neoplasm (47) 47
clinical-trial (46) 46
drug therapy (46) 46
metastasis (45) 45
epothilone (44) 44
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
medicine & public health (43) 43
research (42) 42
neoplasm metastasis (40) 40
hematology, oncology and palliative medicine (39) 39
antineoplastic agents (38) 38
antineoplastic agents - adverse effects (37) 37
microtubule-stabilizing agents (36) 36
plus capecitabine (36) 36
clinical trials as topic (35) 35
docetaxel (34) 34
antimitotic agents (33) 33
epothilones - pharmacology (33) 33
neoplasms - drug therapy (33) 33
phase-ii trial (33) 33
clinical trials (32) 32
resistant (32) 32
solid tumors (31) 31
aged, 80 and over (30) 30
antineoplastic agents - pharmacology (30) 30
health aspects (30) 30
metastatic breast-cancer (30) 30
animals (29) 29
anthracyclines (29) 29
antineoplastic agents - administration & dosage (29) 29
dosage and administration (27) 27
taxoids - therapeutic use (26) 26
b analog (25) 25
daily schedule (25) 25
epothilones - pharmacokinetics (25) 25
pharmacology/toxicology (25) 25
taxanes (25) 25
ixabepilone plus capecitabine (23) 23
tubulin modulators - adverse effects (23) 23
drug resistance (22) 22
drug administration schedule (21) 21
phase-iii trial (21) 21
tumors (20) 20
1st-line therapy (19) 19
deoxycytidine - analogs & derivatives (19) 19
obstetrics and gynecology (19) 19
therapy (19) 19
trial (19) 19
tubulin modulators - administration & dosage (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
patient outcomes (18) 18
prostatic neoplasms - drug therapy (18) 18
review (18) 18
tubulin modulators - pharmacology (18) 18
bevacizumab (17) 17
prostate cancer (17) 17
tubulin (17) 17
antineoplastic agents - pharmacokinetics (16) 16
cancer research (16) 16
fluorouracil - analogs & derivatives (16) 16
peripheral nervous system diseases - chemically induced (16) 16
epothilone-b-analog (15) 15
microtubules (15) 15
neoplasm staging (15) 15
advanced solid tumors (14) 14
analysis (14) 14
complications and side effects (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CLINICAL CANCER RESEARCH, ISSN 1078-0432, 03/2015, Volume 21, Issue 6, pp. 1237 - 1239
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2008, Volume 61, Issue 5, pp. 751 - 758
Journal Article
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2007, Volume 25, Issue 4, pp. 335 - 341
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 02/2008, Volume 95, Issue 2, pp. 197 - 204
Journal Article
2006, AD-a462 812.
This grant report includes a summary of the accomplishment of the statement of work, in addition to the complete protocol, consent, and Contracts and Grants... 
mitoxantrone | prostate cancer | chemical analogs | hormones | refractory materials | hrpc(hormone refractory prostate cancer) | clinical trials | epothilone | prednisone | chemotherapy | bms-247550(ixabepilone)
Government Document
Journal Article
Cancer, ISSN 0008-543X, 08/2007, Volume 110, Issue 4, pp. 759 - 763
BACKGROUND. Paclitaxel and docetaxel are active agents in advanced urothelial cancer. BMS‐247550 (ixabepilone) has activity in preclinical models in paclitaxel... 
phase 2 trial | ixabepilone | urothelial carcinoma
Journal Article
Tetrahedron, ISSN 0040-4020, 08/2019, Volume 75, Issue 33, pp. 4570 - 4576
Synthesis of the C1–C13 fragment of eribulin mesylate has been accomplished. It features a highly stereoselective construction of a -dihydropyran framework... 
EPOTHILONE-B ANALOG | II CLINICAL-TRIAL | IXABEPILONE BMS-247550 | HALAVEN(R) SYNTHESIS | CHEMISTRY, ORGANIC | PHASE-II | STEREOSELECTIVE-SYNTHESIS | BUILDING-BLOCK | PHOSPHORORGANISCHE VERBINDUNGEN | MACROCYCLIC KETONE ANALOGS | POLYHALOGENATED NUCLEOPHILES | Eribulin mesylate | Fine chemicals
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 09/2018, Volume 157, pp. 925 - 934
Epothilones are a class of 16-membered macrolide compounds targeting microtubules. They have good anticancer activity and their mechanism of action is similar... 
Epothilone B | Antitumor activity | Targeting microtubules | Semi-synthesize | Totally synthesize | CHEMISTRY, MEDICINAL | ANALOG | BMS-247550 | CHEMOTHERAPY | PACLITAXEL | BREAST-CANCER | MICROTUBULE-STABILIZING AGENTS | II CLINICAL-TRIAL | IXABEPILONE | PHARMACOPHORE | MUTATIONS | Antimitotic agents | Antineoplastic agents | Green technology
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2008, Volume 14, Issue 22, pp. 7167 - 7172
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.